Fredag 10 Oktober | 19:44:21 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-05-07 N/A Årsstämma
2026-05-07 08:30 Kvartalsrapport 2026-Q1
2026-02-20 08:30 Bokslutskommuniké 2025
2025-10-30 08:30 Kvartalsrapport 2025-Q3
2025-10-10 N/A Extra Bolagsstämma 2025
2025-08-11 - Kvartalsrapport 2025-Q2
2025-05-08 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2025-05-07 - Årsstämma
2025-05-07 - Kvartalsrapport 2025-Q1
2025-02-20 - Bokslutskommuniké 2024
2024-10-31 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-08 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2024-05-07 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-22 - Bokslutskommuniké 2023
2023-10-31 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2023-05-25 - Årsstämma
2023-05-03 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-02 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-30 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2022-05-27 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-24 - Extra Bolagsstämma 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-28 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2021-05-27 - Årsstämma
2021-04-28 - Kvartalsrapport 2021-Q1
2021-02-17 - Bokslutskommuniké 2020
2020-11-03 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2020-05-27 - Årsstämma
2020-04-28 - Kvartalsrapport 2020-Q1
2020-02-17 - Bokslutskommuniké 2019
2019-10-31 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-06-04 - Årsstämma
2019-05-23 - X-dag ordinarie utdelning LUMITO 0.00 SEK
2019-04-30 - Kvartalsrapport 2019-Q1
2019-02-15 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriMedicinteknik
Lumito specialiserar sig på medicinsk teknik för digital patologi. Bolaget strävar efter att förbättra vävnadsdiagnostiken med sin patenterade teknologi baserad på uppkonverterade nanopartiklar. Bolaget planerar att initialt lansera sin första produkt för forskningslaboratorier. Bolaget bildades under 2010 som en spinoff från en forskargrupp vid Lunds universitets avdelning för atomfysik och lasercentrum. Lumito har sitt huvudkontor i Lund.
2025-09-18 14:50:00

Lumito AB (publ) (“Lumito” or the “Company”), which has developed a solution for advanced tissue analysis based on upconverting nanoparticles (UCNPs), has been selected for Business Sweden’s prestigious scale-up programme, Catalyst 2025. The programme brings together Sweden’s most innovative and promising growth companies, with the aim of supporting commercial expansion in a market chosen by the Company.

Lumito is one of three companies admitted to this year’s Catalyst programme. By participating, the Company will gain access to specialised strategic support in marketing, market entry, networking, pitching opportunities to leading industry players, advisory services, and invitations to relevant events. The support provided through the programme corresponds to a value of approximately SEK 250,000.

Within the framework of Catalyst 2025, Lumito will focus on continuing its market introduction in the United Kingdom – a strategically important market for the Company’s research platform, SCIZYS, and a market with a strong global position in pharmaceutical development, as well as a large number of leading Contract Research Organisations (CROs), which is a key segment for Lumito. The Company already collaborates with the UK-based CRO, Concept Life Sciences.

“Being selected for the Catalyst programme is a clear recognition of our international potential and, at the same time, a significant opportunity to accelerate our commercial establishment in the United Kingdom. It is a great honour to have been chosen in such strong competition, and we look forward to working closely with Business Sweden and their local experts to build business relationships and deepen collaborations in the UK market,” says Sanna Wallenborg, CEO of Lumito.

Business Sweden’s Catalyst programme offers strategic support for market development, partnerships, and business growth, with the aim of scaling up Swedish growth companies in selected international markets.

Read more about the Catalyst scale-up programme.